Better understanding of the mechanisms underlying the developmental progression of neural stem cells (NSCs) in the cerebral cortex is important for modeling neurogenesis and defining the pathogenesis of neuropsychiatric disorders. Here we used RNA-sequencing, cell imaging and lineage tracing of mouse, macaque and human neurogenesis, along with single-cell RNAsequencing and immuno-labeling to explore how cortical glutamatergic excitatory neurons are generated in vitro and in vivo. This analysis revealed that conserved signaling mechanisms regulate glutamatergic neurogenesis among the three species. We then show that as human telencephalic NSCs develop in vitro, they first generate the organizer states that spatially pattern the cortex before progressing to excitatory neuronal fates. This developmental progression of human NSCs in vitro opens to systematic analysis key aspects of human-specific area patterning during cortical neurogenesis.
SUMMARY
Better understanding of the mechanisms underlying the developmental progression of neural stem cells (NSCs) in the cerebral cortex is important for modeling neurogenesis and defining the pathogenesis of neuropsychiatric disorders. Here we used RNA-sequencing, cell imaging and lineage tracing of mouse, macaque and human neurogenesis, along with single-cell RNAsequencing and immuno-labeling to explore how cortical glutamatergic excitatory neurons are generated in vitro and in vivo. This analysis revealed that conserved signaling mechanisms regulate glutamatergic neurogenesis among the three species. We then show that as human telencephalic NSCs develop in vitro, they first generate the organizer states that spatially pattern the cortex before progressing to excitatory neuronal fates. This developmental progression of human NSCs in vitro opens to systematic analysis key aspects of human-specific area patterning during cortical neurogenesis.
INTRODUCTION
Defining how cell types emerge in the forebrain is a central topic in the quest to understand the origins of the normal and pathological function of the cerebral cortex (Geschwind and Rakic, 2013; Kwan et al., 2012b; Lein et al., 2017; Nowakowski et al., 2017; Sandberg et al., 2016; Wamsley and Fishell, 2017) . The excitatory and inhibitory neurons of the cortex emerge in two different rostral neuroepithelial zones, the dorsal and ventral telencephalon (Kwan et al., 2012b; Sandberg et al., 2016; Wonders and Anderson, 2006) . Evidence of genetic risk for neuropsychiatric disorders has been found in the patterns of genes expressed in the midfetal neurogenic cortex (Gulsuner et al., 2013; Parikshak et al., 2013; State and Sestan, 2012; Willsey et al., 2013; Xu et al., 2014) . Moreover, risk associated genes have been identified in the in vitro functional phenotypes of NSCs derived from patient-specific induced pluripotent stem cells (iPSCs) (Brennand et al., 2015; Consortium, 2017; Fujimori et al., 2018; Lang et al., 2018; Madison et al., 2015; Marchetto et al., 2016; Mariani et al., 2015) . Thus, understanding the signaling specifying cortical NSCs in vitro is required to define pathogenic mechanisms and develop new therapies for brain disorders.
The neocortex in mammals, including rodents and humans, is the product of fate transitions of radial glial cells (RGCs) sequentially generating in the proliferative zones post-mitotic neurons, that migrate to distinct overlying cortical layers where they carry out different circuit functions (Angevine and Sidman, 1961; Rakic, 1974 Rakic, , 1988 . This in vivo evidence points to the importance of accurately defining how cortical neuronal fate commitment is controlled in vitro. It is well established that in cell culture, the growth factor status of the medium regulates the transition from proliferating NSCs to differentiated progeny (Cattaneo and McKay, 1990; Johe et al., 1996; Ravin et al., 2008) . Widely studied intracellular regulators of NSC growth include the Rasextracellular signal-regulated kinase (RAS-ERK) and the phosphatidylinositol 3 kinase-protein kinase B-mammalian target of rapamycin (PI3K-AKT-mTOR) signaling pathways, that also play a major role in brain cancer, as well as neurodevelopmental diseases (Crawley et al., 2016; Ernst, 2016; Mendoza et al., 2011) . FGF2, insulin and other extracellular ligands, acting through the MAPK/ERK and PI3K/AKT pathways on the expression of cell cycle regulators, control the critical transition when cortical NSCs initiate neurogenesis, both in brain development and cell culture (Adepoju et al., 2014; Androutsellis-Theotokis et al., 2006; Lehtinen et al., 2011; Qi et al., 2017; Rash et al., 2011; Vaccarino et al., 1999) . The withdrawal of the NSC growth factor FGF2 has been widely used to stimulate neurogenesis in vitro (Cattaneo and McKay, 1990; Johe et al., 1996) , and lineage analysis under this condition directly demonstrates rapid commitment of multipotential NSCs to neuronal and glial fates . However, we lack direct evidence showing that cortical neurons are specified when they become post-mitotic in vitro. Here, we show that modulating FGF2-MAPK signaling controls the timing of cell cycle exit and the developmental progression of NSCs to distinct differentiation trajectories. This analysis demonstrated that specification of glutamatergic excitatory cortical neurons is dependent on conserved signaling mechanisms operating as proliferating mouse and human NSCs become post-mitotic.
In the developing mammalian telencephalon, before neurons are specified, organizer centers emerge to pattern different cortical domains (Geschwind and Rakic, 2013; Grove and Fukuchi-Shimogori, 2003; O'Leary et al., 2007; Sur and Rubenstein, 2005) . Recent reports of speciesspecific differences in corticogenesis are often focused on relatively late neurogenic stages where there is an enhanced genesis of superficial neurons in the primate outer subventricular zone (oSVZ) (Namba and Huttner, 2017; Nowakowski et al., 2016; Zhu et al., 2018) . However, evolutionary expansion of the cerebral primordium is evident from the earliest stages, even before the onset of corticogenesis, and is already prominent when RGCs produce the first glutamatergic neurons (Bystron et al., 2008; Geschwind and Rakic, 2013) . Thus, there is a clear interest in defining the early signaling mechanisms that specify neurogenesis in different mammalian species, including humans. Building on previous work (Edri et al., 2015) , we now show that NSCs derived in vitro from human PSCs self-organize to sequentially occupy different developmental stages. Early passages of human NSCs were highly enriched in cells expressing genes characteristic of the cortical hem, an organizer zone that patterns the neocortex (Caronia-Brown et al., 2014) . At later passages the neural rosettes representing excitatory cortical neuronal precursors were generated at high frequency. These data indicate that cortical patterning mechanisms and neuronal fate commitment are coordinated features that progress under precise controls in NSCs in vitro, providing access into the early mechanisms specifying the cellular architecture of the human cerebral cortex.
RESULTS

Early FGF2 signaling in mouse NSCs regulates cortical neurogenesis in vitro
Rodent cortical NSCs proliferate maximally in the presence of 10 ng/ml FGF2 and abruptly differentiate when this growth factor is withdrawn, in vitro (Adepoju et al., 2014; Cattaneo and McKay, 1990; Ravin et al., 2008) . Here, primary NSC cultures were derived from mouse dorsal telencephalon at the beginning of neurogenesis, embryonic day 11.5 (E11.5), and expanded. NSCs were exposed to a range of FGF2 doses (0.1, 1, or 10 ng/ml) for 48 hours after passage, and their later differentiation monitored ( Figure 1A ). The cultures exposed to lower (0.1 or 1.0 ng/ml) rather than the higher (10 ng/ml) dose of FGF2 generated more neurons, assessed at day in vitro (DIV) 15 ( Figure 1B ). Molecular differences between cortical glutamatergic excitatory projection (pyramidal) neurons have been used to define the appearance of distinct neuron subtypes found in different layers (Kwan et al., 2012b; Molyneaux et al., 2007; Shen et al., 2006) ( Figure S1A ). The highest FGF2 dose (10 ng/ml) generated lower numbers of neuron types at all times, as defined by immunostaining for TLE4 and CUX1, well established markers of deep and upper layer projection neurons ( Figure 1C ). These results show that the FGF2 signaling status of NSCs exiting the cell cycle regulates the generation of glutamatergic neurons.
Next, we examined the distribution of synapses and electrophysiological activity after two weeks of neurogenesis ( Figure 1D and S1B). The density of puncta expressing the synaptic marker Synapsin 1 (SYN1) was significantly higher in neurons derived from the low FGF2 conditions ( Figure S1B ). The synaptic proteins Homer1 (HOM1) and PSD95, and the density of puncta colocalizing these pre-and post-synaptic markers were higher in neurons derived from treatment with 1 ng/ml FGF2 ( Figure S1B ), which also showed the highest frequency of spontaneous excitatory postsynaptic currents (EPSC) ( Figure 1D ). Similar results were observed later at DIV 22 ( Figure S1C ). These data confirm that FGF2 signaling during the initial in vitro differentiation of NSCs regulates the number, type and activity of the derived cortical neurons many days later.
Waves of transcriptional dynamics during mouse in vitro neurogenesis
To gain insight into the transcriptional dynamics responsible for these changes in neuronal differentiation, mouse cortical NSCs were exposed to varying doses of FGF2 and total RNA was collected for deep sequencing (RNA-seq), from 6 hours to 12 days of differentiation ( Figure 1A ).
Principal component analysis (PCA) defined progressive differentiation in PC1 ( Figure S2A ) indicating NSCs exposed to lower FGF2 concentrations moved more rapidly through this major transition in gene expression.
Gene expression data can be visualized or "projected" into a low-dimensional space defined by another data set. This allows the exploration of transcriptional modules of the first data set as they change in the new data space. To relate the dynamics of mouse NSCs in vitro to in vivo cortical development, we projected expression data from the developing human (Jaffe et al., 2018) and macaque neocortex (Bakken et al., 2016) into the transcriptional space defined by the individual gene weights from PC1, using ProjectR ( Figure S2Bi To gain a higher resolution view of transcriptional dynamics during neural differentiation, we employed the genome-wide CoGAPS (GWCoGAPS) non-negative matrix factorization (NMF) method, that assigns weights for the contribution of every gene to a set number of patterns, to represent dominant changes in gene expression across all the in vitro samples (Fertig et al., 2014; Stein-O'Brien et al., 2017) . GWCoGAPS analysis, identifying 11 patterns (p1-11; Figure 1E and S2C and D), defined sequential waves of transcriptional extinction and induction as NSCs differentiated. Hierarchical clustering ordered these patterns into three groups associated with:
(1) NSC expansion (p5 and p6); (2) initiation of neural differentiation (p1, p11, p7, p9 and p10); and (3) further maturation (p9, p10, p4 and p8) ( Figure S2C and D). The early patterns (p5 and p6) were maintained in high FGF2 dose and enriched in cell cycle regulator genes, defined by GO analysis ( Figure 1E ). As differentiation proceeds, the initial FGF2 condition controlled sequential waves of gene expression in the first 6 days of differentiation (patterns p1, p11, p7 and p9) ( Figure 1E and S2D). For later steps of differentiation, GO analysis defined distinct end points for low and high FGF2 conditions that reflect either terminal neuro-(p8; low FGF2) or glio-(p4; high FGF2) genesis ( Figure 1E ).
These data show that NSCs passaged into low FGF2 doses abruptly down regulated cell cycle genes and traversed later steps of neuron differentiation more rapidly ( Figure S3A and B).
Consistent with this transcriptional analysis and our previous work (Adepoju et al., 2014) , phosphorylation of MAPK/ERK and expression of Cyclin D1 were sensitive to FGF2 dose ( Figure   S3C ), and synaptic maturation genes including CaMKIIα increased when NSCs abruptly left the cell cycle in low FGF2 ( Figure S3D ). This analysis defines dynamic waves of transcription, initiated by variation in FGF2 signaling as NSCs exit the cell cycle, implementing distinct differentiation trajectories biased towards either cortical neurons or glia.
Endogenous early BMP function is required for mouse cortical neurogenesis
To more precisely define the events initiating the differentiation of dorsal telencephalic neurons in vitro, we focused on BMP signaling that is known to oppose FGFs in patterning the telencephalon in vivo and regulating NSC differentiation in vitro (Lehtinen et al., 2011; Lillien and Raphael, 2000; Mabie et al., 1999; Tiberi et al., 2012) . When the expression patterns of BMP signaling genes were analyzed during in vitro neurogenesis, distinct waves of expression correlated with particular BMP ligands and BMP responsive gene sets were observed ( Figure 1E patterns p7, 2A-D and S4A). Nuclear phosphorylated SMAD1/5 (pSMAD1/5) signal showed transient and rapid induction of endogenous BMP signaling in low FGF2 dose ( Figure 2E ), alongside BMP4 and Noggin mRNA expression ( Figure 2B and D).
To determine if this early BMP signaling had a significant effect on later steps of neuronal maturation, BMP type I receptors were blocked with the inhibitor LDN193189, at 12 hours after plating and prior to BMP4 transcription. The early inhibition of BMP signaling blocked both pSMAD1/5 induction at DIV 2 and the subsequent synaptic maturation seen at DIV 15 at low FGF2 doses ( Figure 2F and 2G). NOTCH and WNT signaling genes also showed temporal dynamics across neurogenesis ( Figure S4B ), suggesting that these signaling pathways also orchestrate these transitions. The data shown here indicate that FGF2 regulated an endogenous BMP signaling wave during the transition from proliferation to differentiation that was necessary for cortical neurogenesis and synaptic maturation.
Two mouse cortical NSC subtypes show selective FGF2 induced BMP signaling activation and distinct fate bias
We previously demonstrated that rodent cortical NSCs consist of a heterogeneous and dynamic population with varying lineage potential . To further explore NSC diversity during cortical neurogenesis in vitro, we interrogated the surface expression of the tyrosine kinase receptors PDGFRα and EGFR which mark subsets of NSCs in vitro and in vivo (Jackson et al., 2006; Lillien and Raphael, 2000; Sun et al., 2005) . Remarkably, the proportion of PDGFRαhigh and EGFRhigh cells was regulated by FGF2 dose in the first 2 days in vitro and the expression of the receptors was mutually exclusive and decresed at DIV 6, indicating that FGF2 treatment induces a transient wave of EGFR positive cells from a PDGFR positive state ( Figure   3A and S5A).
Time-lapse recording and lineage analysis showed that FGF2 signaling controlled the cell cycle duration of EGFRhigh cells ( Figure S5B ). EGFRhigh cells showed higher levels of phosphorylated FGF receptor (pFGFR) and pERK across all FGF2 doses ( Figure S5C ), but no differences in FGFR2, FGFR1 and FGFR3 expression were seen ( Figure S5C , not shown). HES1 and PAX6 expression were higher in EGFRhigh cells, while SOX2 expression level was higher in PDGFRαhigh cells ( Figure S5D ). Consistent with the induction of endogenous BMP signaling as cortical neurons differentiate, phospho-SMAD1/5 and BMPR1A levels were higher in EGFRhigh cells ( Figure 3B ). These results show that the FGF2 status at cell passage initiates BMP signaling in a transient EGFRhigh differentiating state.
To assess the fate bias of these different NSC subtypes, we performed time-lapse recording to create lineage dendrograms linking EGFRhigh or PDGFRαhigh founder cells at DIV 1 to the corresponding neurons, oligodendrocytes and astrocytes, identified at DIV 6 by expression of TuJ1, O4 or GFAP ( Figure S6Ai ; Video S1-3). PDGFRαhigh progenitors generated similar proportions of oligodendrocytes and neurons in low FGF2 conditions, and predominantly gave oligodendrocytes at the higher FGF2 dose. EGFRhigh cells were tripotent, both in 1 and 10 ng/ml FGF2. Importantly, the timing of lineage specification events (see methods and ) showed that increasing FGF2 doses delays cell cycle exit and shifts fate specification to later generations ( Figure 3C and S6Aii).
To lineage trace neurons at more mature stages of differentiation (DIV 15), we employed adenoassociated viruses (AAV) encoding green fluorescent protein (GFP) with preferential tropism for cells expressing either PDGFRα (AAV5) or EGFR (AAV6) (Di Pasquale et al., 2003; Jackson et al., 2006; Weller et al., 2010) (Figure S6B and C). AAV6-infected cells preferentially generated CUX1 + , FOXP2 + , or TLE4 + glutamatergic neurons, while AAV5-infected cells generated more GAD65 expressing putative GABAergic neurons with less complex neuronal morphologies ( Figure 3D and S6D). These results indicate that mouse telencephalic NSCs exposed to low FGF2 generate an EGFRhigh BMP responsive cell that specifically differentiates to neurons with cortical glutamatergic fates.
Cortical neuron differentiation bias varies with the passage of human NSCs
Neuroepithelial fates with dorsal telencephalic features can be generated from human pluripotent stem cells in vitro (Edri et al., 2015; Mariani et al., 2012; Shi et al., 2012) , however the specific details of neuronal commitment are not known. To explore the mechanisms of human cortical neurogenesis, we differentiated the embryonic stem cell (ESC) line H9 to telencephalic NSCs that were then serially passaged ( Figure S7A ) (Chambers et al., 2009; Edri et al., 2015) . hNSCs grown in 20 ng/ml FGF2 were analyzed for the expression of the fate regulators SOX2, HES1, HES5, OTX2, PAX6 and SOX21 through passages 1 to 5 (PS1-5) ( Figure S7B and C). The results show the spontaneous emergence and decline of the rosette-forming neurogenic state, providing a rich substrate to define human neurogenic mechanisms.
To explore the neurogenic potential of these dynamic NSC states, RNA-seq was performed 6 days after hNSCs were exposed to varying concentrations of FGF2 at the terminal passage, from passages 1 to 8 (PS1-PS8; see Methods) ( Figure 4A and S7A). PC1 revealed transcriptional progression across passages that was independent of FGF2 treatment ( Figure S7Di ). Projection analysis using ProjectR indicated parallels between the transcriptional dynamics identified by PC1 in vitro and the developing human (Jaffe et al., 2018) and macaque (Bakken et al., 2016) cortices ( Figure S7Dii and iii). To characterize these transcriptional dynamics at a more granular level, we explored a set of 24 patterns (p1-24) defined by the GWCoGAPS NMF algorithm in the hNSC RNA-seq dataset that describe gene expression change upon FGF2 modulation at every passage ( Figure S8A ). Patterns p5, p6 and p22 showed transcriptional differences across FGF2 dose specific to PS4, when neural rosettes were most abundant (Figure 4Bi and S8A, S7B and C). Projection of macaque data (Bakken et al., 2016) into these patterns shows that p5 specifically identifies a gene signature that is highly expressed in the forming cortical plate (CP) over the germinal domains SVZ and VZ throughout this neurogenic period (Figure 4Bii ).
To more precisely relate the in vitro transcriptional dynamics to discrete cell types of the developing primate neocortex, we performed single-cell mRNA sequencing (scRNA-seq) in E78 rhesus macaque embryonic dorso-lateral prefrontal cortex (DLPFC) using 10x Genomic platform.
Data from 4376 single cells passed quality control meaures and were included in the present study. Using unsupervised clustering, we identified 6 distinct clusters representing excitatory neurons, NSCs, oligodendrocytes, microglia, astrocytes and endothelial cells ( Figure S9A and B) .
Projection of these scRNA-seq data into gene weights from in vitro hNSC GWCoGAPS patterns confirms that p5 correlated with post-mitotic neurons in vivo (Figure 4Biii ). Of note, p22, induced by high FGF2 treatment, was not associated with a neurogenic signature in either projection.
These results indicate that the in vitro appearance of new-born cortical neurons was favored specifically at PS4 by acute reduction of FGF2 and, importantly, suggests that parallel gene expression dynamics occurred in vitro and in the neurogenic primate neocortex.
Immunofluorescence was used to further explore the differentiation of post-mitotic neurons from PS4 hNSCs. The data show that low FGF2 favored a switch from proliferating (EDU + ) hNSCs, SOX2 + and PAX6 + , to PAX6 -, SOX2 -, TuJ1 + , EGFRhigh, Doublecortin (DCX) + -expressing postmitotic (EDU -) early-born neurons ( Figure 4C and S7B, S8Biii-v and C). Elevated pSMAD1/5 immunoreactivity showed that differentiation in low FGF2 was associated with a burst of endogenous BMP signaling, which occurs specifically at the neurogenic passage PS4 ( Figure 4C and S8B).
When PS4 hNSCs were differentiated for a more extended period, more neurons expressing markers of cortical layers (TBR1, FOXP2 or SATB2) and showing synaptic activity and action potentials were derived from hNSCs treated with low doses of FGF2 ( Figure 4D and E, and S8D) .
These results suggest that neurons with cortical glutamatergic features were specified by a conserved mechanism in human and mouse NSCs and, importantly, that hNSCs differ with the passage in the generation of these pertinent neuronal intermediates ( Figure S8Bi-iv) .
EGFR-BMP signaling interaction defines an early neuronal transition state of RGCs in developing primate cortex
Next, we investigated in rhesus macaque whether the developmental progression of NSC states in vivo resembled that seen in vitro. In the prenatal macaque dorsal parietal cortex, EGFRhigh/PAX6 + RGCs, detected by immuno-histochemistry in the VZ/iSVZ at E70, but not at the beginning of corticogenesis at E55 (not shown), identified neural progenitors and early committed neurons (Hansen et al., 2010; Mo and Zecevic, 2008 ) that delaminated spanning the oSVZ (Figure 4Fi , ii, and S9Ci). The induction of nuclear pSMAD1/5 in the EGFRhigh RGCs indicates BMP signaling response in the VZ/iSVZ, which is an early step in neuronal differentiation (Lehtinen et al., 2011; Li et al., 1998; Saxena et al., 2018) (Figure 4Fii and iii, S9Cii). Moreover, we found EGFRhigh RGCs expressing the neurogenic transcription factors EOMES/TBR2 and NEUROD1 in iSVZ, confirming neuron fate commitment of these cells (Figure 4Fiii and iv, S9Cii and iii) (Arnold et al., 2008; Englund et al., 2005; Pollen et al., 2015) . Interestingly, EGFR staining was not detected in cells expressing late neuronal markers, such as TBR1 + cells in the cortical plate, and no EGFRhigh/NEUROD1 + cells were found in the intermediate zone or CP ( Figure 4Fv and S9Cii and iii).
The dynamics of expression of genes as human telencephalic neural stem cells become postmitotic was explored in a single cell RNA-seq data (Nowakowski et al., 2017) . The overall structure of cell types in these data was established by tSNE analysis demonstrating the clear distinction between the cascade of differentiating neurons seen in the ventral and dorsal telencephalon ( Figure S9D ). Proliferative and non-proliferative neuronal intermediate precursors cells (IPCs) in the dorsal telencephalic trajectory were identified ( Figure 4G ). Proliferating TBR2 + /SOX2 + neuronal IPCs could also express EGFR and respond to endogenous BMPs, while more mature non-cycling TBR2 + cells were SOX2 -/EGFRand negative for any BMP signaling related gene ( Figure 4G and S9D) . These data confirm that dynamic EGFR expression is an early and transient step in the generation of neurons from RGCs, in primate cortical neurogenesis.
Together, these results are consistent with the hypothesis that in the mid-neurogenic phase of monkey and human cortex, an EGFRhigh cell population employing BMP signaling is an early transition state from proliferative RGCs to committed glutamergic cortical neurons.
Early passage human NSC states show cortical organizer identities
These events specifying cortical excitatory neuronal fates occur in vivo in a spatially constrained neuro-epithelial sheet patterned by morphogenetic signals from adjacent organizer domains. To understand how cortical neuronal precursors at PS4 were generated, we focused on the GWCoGAPS patterns from the in vitro hNSC data showing the highest gene expression in PS2 and PS3 (Figure 5Ai and S10Ai). Patterns p2, p11, p4 and p19 but not p8 were dependent on the initial FGF2 status of the cells. These transcriptional dynamics at PS2 and PS3 suggest these early stages of human NSCs also undergo a differentiation response regulated by FGF-MAPK signaling and we explore their meaning further.
Projection of the developing macaque cortex gene expression data (Bakken et al., 2016) into these patterns showed that p8 and the low FGF2 patterns p11 and p2 were most highly represented in the cortical hem domain (Figure 5Aii ; (Bakken et al., 2016) ). Importantly, neither the high FGF2 patterns p4 and p19, nor the later patterns p5 and p22 (described above), showed enrichment in genes of the cortical hem domain ( Figure S10Aii and 4Bii ). This analysis indicates that the low FGF2 conditions at early passages p2 and p3 induced elements of the hem transcriptional signature. The cortical hem zone is a source of BMP and WNT morphogens that pattern the dorsal and caudal domain of the telencephalon (Caronia-Brown et al., 2014; Grove et al., 1998) . In order to monitor the emergence of this cellular organizer identity across the passages, we used the gene expression data from the developing macaque cortex (Bakken et al., 2016) to generate a list of hem-specific genes (see Methods; Figure 5B ). Passages 2 and 3 were enriched in these genes including LMX1A, WNT8B, WNT3A, BMP2/4/6/7, RSPO1/2/3 and BAMBI indicating coordinated expression at early passages in vitro of many hem regulators ( Figure 5B and S10B).
Consistent with the known function of LMX1A in mouse organizers including the cortical hem (Chizhikov et al., 2010) , expression of this transcription factor (TF) was highest at PS2 in low FGF2 and subsequently decreased (Figure 5Ci and iv) . In contrast, the TFs FOXG1 and LHX2, which are required in the mouse to form the medial pallium and lateral cortex and to repress the formation of the cortical hem (Bulchand et al., 2001; Hanashima et al., 2007; Mangale et al., 2008; Molyneaux et al., 2007; Monuki et al., 2001) , appeared at later passages (Figure 5Ci , ii, iv, v). At passage 3, the majority of cells expressed LMX1A or LHX2, suggesting co-emergence of the caudal hem organizer and the precursor cells of the cortical field (Figure 5Civ ). The expression patterns of genes such as FGF8, TTR, and SFRP2 at these early passages suggest that the anterior patterning center, the choroid plexus, and the antihem were also represented ( Figure S10C ). The progressive appearance at PS3 of OTX2 + , a transcriptional regulator of the choroid plexus and cortical hem (Sakaguchi et al., 2015) , FOXG1 + cells and then of OTX2 -, FOXG1 -, EGFRhigh cells at PS4 (Figure 5Cii , iii and v) confirms these hNSCs progress from a hem-to a cortex-like identity ( Figure 5C and D) . This coordinated change indicates that cortical patterning and neuronal specification mechanisms are efficiently executed across early passages of human neural precursors in vitro.
DISCUSSION
Controlling the early cellular events during neurogenesis is essential to model brain development.
In the present study, we first definitively show that proliferating mouse and human NSCs commit to excitatory cortical neuronal fates as they become post-mitotic. Prior to the phase when excitatory neurons were most efficiently generated, human NSCs transitioned through organizer and pallial precursor states recapitulating early steps in the patterning and neurogenesis of the cerebral cortex. The mechanisms of neuronal commitment in primary mouse and human cortical NSCs expanded in vitro were analyzed using a combination of cell lineage, signaling and transcriptomic tools. These results defined molecular and cellular dynamics at the time NSCs become post-mitotic and commit to cortical excitatory neuronal fates. Remarkably, FGF2 signaling generated asymmetry within NSC progenitors in vitro, instructing populations characterized by high levels of EGFR expression to take on cortical neuronal fates. When mouse and human NSCs were passaged in low doses of FGF2, EGFRhigh cells responsive to endogenous BMP signaling were generated as cortical glutamatergic neurons first differentiated.
At higher FGF2 concentrations we observed delayed BMP activity and additional cycles of proliferation prior to cell cycle exit, leading preferentially to glial (oligodendrocytic and astrocytic) and neuronal fates that did not include canonical excitatory neurons. The results here support a model where the commitment of NSCs to cortical neuronal fates is determined by modular cell state progressions initiated by the precise signaling conditions active during cell cycle exit.
Extending previous work identifying EGFR expressing cells as astro-glial precursors of the late SVZ in rodents (Burrows et al., 1997; Lillien and Raphael, 2000; Sun et al., 2005) and monkey (Rash BG et al, PNAS 2019, in press) From the first generation of neurons from pluripotent sources in vitro (Kim et al., 2002; Okabe et al., 1996) to the many recent studies of the transcriptomic and epigenetic landscapes of the developing cerebral cortex (de la Torre-Ubieta et al., 2018; Nowakowski et al., 2017; Zhu et al., 2018) , it is becoming clear that NSC differentiation requires precise temporal and spatial regulation of cellular identities. Here, after demonstrating the most efficient generation of excitatory neurons occurred at a specific early passage, we explored the origins of this neurogenic state focusing on the regional patterning mechanisms, known in vivo to intrinsically coordinate the overall cortical structure prior to the inputs induced by the thalamic afferents (Armentano et al., 2007; Bishop et al., 2000; Cholfin and Rubenstein, 2007; Miyashita-Lin et al., 1999; Nakagawa et al., 1999; Shimogori and Grove, 2005) . The two-dimensional architecture of the cortical field emerges from signaling interactions between the developing dorsal telencephalon and spatially constrained specialized organizer cells (Fukuchi-Shimogori and Grove, 2001; Rash and Grove, 2006) . We demonstrate the precise appearance of organizer and cortical precursor domains in vitro, providing an unprecedented opportunity to define how morphogenetic spatial patterning is co-ordinated with the specification of excitatory neurons in different regions of the human dorsal telencephalon.
The early developmental mechanisms operating in the telencephalon are proximal to genetic risk for neurodevelopmental disorders including autism spectrum disorder (ASD) (Marchetto et al., 2016; Mariani et al., 2015) , bipolar disorder (Madison et al., 2015) , fragile X syndrome (Kwan et al., 2012a) , Huntington's disease (Consortium, 2017 ) and brain cancers (Crawley et al., 2016; Ernst, 2016) . In the context of an unprecedented transcriptomic and epigenetic mapping of the human central nervous system (Amiri et al., 2018; de la Torre-Ubieta et al., 2018; Wang et al., 2018; Zhu et al., 2018) , progress continues in defining disease relevant in vitro phenotypes as a central tool in the development of novel therapeutic interventions (Fujimori et al., 2018; Hubler et al., 2018; Lang et al., 2018) . To achieve accurate models of risk for neuropsychiatric disease, it will be valuable to assess how patient-specific iPSCs vary as they progress through the non-linear developmental transitions described here. Our work supports the more precise definition of risk mechanisms by focusing attention on specific cell state transitions which involve TFs including FOXG1, a regulator of neural fate choices in the forebrain and involved in ASD (Mariani et al., 2015) , or EOMES/TBR2 and FGFR2, whose human specific/gained enhancers (HGEs) are known to regulate early cortical fate choices, and their action in the cortical germinal zone, is implicated in neuro-developmental disorders including schizophrenia 
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